Azkarra Therapeutics
PrivateLast Round
Seed
Jun 1, 2020
Company Overview
Azkarra Therapeutics is a biotechnology company that develops next-generation DNA damage response-modulating small molecule therapeutics for cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azkarra Therapeutics Comparables
Compare Azkarra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nodus Oncology | 86% | |
| 858 Therapeutics | 82% | |
| FoRx Therapeutics | 82% | |
Azkarra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2020 |
Key People
Founding team and executive leadership
Azkarra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ShangPharma Innovation | Seed |
| Pandect Bioventures | Seed |
Azkarra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Azkarra Therapeutics's valuation, stock price, and market status.